CRISPR-controlled proteases
Biochemical Society Transactions · 2024
DOI: 10.1042/bst20230962 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemical Society Transactions, 2024. Verfasst von Sam P B van Beljouw und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bionanoscience, Delft University of Technology, 2629 HZ, Delft, Netherlands. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Gene Editing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
With the discovery of CRISPR-controlled proteases, CRISPR–Cas has moved beyond mere nucleic acid targeting into the territory of targeted protein cleavage. Here, we review the understanding of Craspase, the best-studied member of the growing CRISPR RNA-guided protease family. We recollect the original bioinformatic prediction and early experimental characterizations; evaluate some of the mechanistic structural intricacies and emerging biotechnology; discuss open questions and unexplained mysteries; and indicate future directions for the rapidly moving field of the CRISPR proteases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bionanoscience, Delft University of Technology, 2629 HZ, Delft, Netherlands.
- Kavli Institute of Nanoscience, Delft, Netherlands.
ORCID-Profile: Sam P B van Beljouw
Zitieren
APA
van Beljouw, S. P. B., & Brouns, S. J. J. (2024). CRISPR-controlled proteases. Biochemical Society Transactions. https://doi.org/10.1042/bst20230962
Vancouver
van Beljouw SPB, Brouns SJJ. CRISPR-controlled proteases. Biochemical Society Transactions. 2024. doi:10.1042/bst20230962
BibTeX
@article{vanBeljouw2024,
author = {van Beljouw, Sam P B and Brouns, Stan J J},
title = {CRISPR-controlled proteases},
journal = {Biochemical Society Transactions},
year = {2024},
doi = {10.1042/bst20230962}
}
EUVIMED